Leonteq Securities AG
Broker-DealerPosition in AXSM — Axsome Therapeutics, Inc.
CIK 1535950
ZURICH, V8
Position in AXSM
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$640,318
+$193,430 QoQ
Shares Held
2,616
-1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#301
of 503 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Dec 31, 2023CallValue
$31,836
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Leonteq Securities AG holds $31,064,274 across 57 Biotechnology names. AXSM ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
267,131 | $18,707,183 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,948 | $2,461,735 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,433 | $2,202,004 | |
| 4 | BNTX |
BioNTech SE
|
11,461 | $1,066,446 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
27,926 | $958,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
This page
|
2,616 | $640,318 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
150,000 | $624,000 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
15,457 | $602,977 |
All Filings in AXSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $640,318 | 2,616 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $446,888 | 2,644 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $587,918 | 3,219 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $453,858 | 3,737 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $395,116 | 3,785 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $412,287 | 3,535 | Shares | Sole | 2026-02-23 | |
| 2024-12-31 | $299,350 | 3,538 | Shares | Sole | 2026-02-23 | |
| 2024-09-30 | $317,960 | 3,538 | Shares | Sole | 2026-03-04 | |
| 2024-06-30 | $380,201 | 4,723 | Shares | Sole | 2026-03-04 | |
| 2024-03-31 | $304,437 | 3,815 | Shares | Sole | 2026-03-11 | |
| 2023-12-31 | $187,036 | 2,350 | Shares | Sole | 2026-03-11 | |
| 2023-12-31 | $31,836 | 400 | Call | Sole | 2026-03-11 | |
| 2023-09-30 | $27,956 | 400 | Call | Sole | 2026-03-11 | |
| 2023-09-30 | $143,274 | 2,050 | Shares | Sole | 2026-03-11 | |
| 2023-06-30 | $147,313 | 2,050 | Shares | Sole | 2026-03-11 | |
| 2023-03-31 | $61,680 | 1,000 | Shares | Sole | 2026-03-11 | |
| 2022-12-31 | $154,260 | 2,000 | Call | Sole | 2026-03-26 | |
| 2022-12-31 | $7,713 | 100 | Shares | Sole | 2026-03-26 | |
| 2022-09-30 | $142,784 | 3,200 | Shares | Sole | 2026-03-26 | |
| 2022-06-30 | $76,600 | 2,000 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $45,529 | 1,100 | Shares | Sole | 2026-03-26 | |
| No filing history on record for this holder in this stock. | ||||||